HLA-DR anticorps
(1 reference)-
- Antigène Tous les produits HLA-DR
- HLA-DR
-
Reactivité
- Humain
-
Hôte
- Souris
-
Clonalité
- Monoclonal
-
Conjugué
- Cet anticorp HLA-DR est non-conjugé
-
Application
- Flow Cytometry (FACS), Western Blotting (WB), Immunoprecipitation (IP)
- Specificité
- The antibody MEM-12 recognizes a common extracellular epitope on human HLA-DR which is dependent on the association of alpha and beta chains. DR is the isotype of human MHC Class II molecules expressed on antigen-presenting cells (APC, dendritic cells, B lymphocytes, monocytes, macrophages).
- Réactivité croisée (Details)
- Human
- Purification
- Purified by protein-A affinity chromatography.
- Pureté
- > 95 % (by SDS-PAGE)
- Immunogène
- thymocyte membrane
- Clone
- MEM-12
- Isotype
- IgG1
-
anti-HLA-DR (HLA-DR) antibody (FITC)
HLA-DR Reactivité: Humain FACS Hôte: Souris Monoclonal MEM-12 FITC
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reactivité: Humain FACS, WB, IHC, ISt, StM Hôte: Souris Monoclonal TAL 1B5 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reactivité: Humain, Chien, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC Hôte: Souris Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reactivité: Humain, Chien, Non-Human Primate FACS Hôte: Souris Monoclonal L243 PE
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reactivité: Humain FACS, WB, IHC, IF, ISt, StM Hôte: Souris Monoclonal SPM289 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reactivité: Humain FACS, IP Hôte: Souris Monoclonal HL-39 unconjugated
anti-HLA-DR (HLA-DR) antibodyHLA-DR Reactivité: Humain, Chien, Non-Human Primate FACS, WB, IP, IHC (fro), IHC (p), ICC, Func Hôte: Souris Monoclonal L243 unconjugated
anti-HLA-DR (HLA-DR) antibody (PE)HLA-DR Reactivité: Humain FACS Hôte: Souris Monoclonal MEM-12 PE
anti-HLA-DR (HLA-DR) antibody (APC)HLA-DR Reactivité: Humain FACS Hôte: Souris Monoclonal MEM-12 APC
anti-HLA-DR (HLA-DR) antibody (PerCP)HLA-DR Reactivité: Humain FACS Hôte: Souris Monoclonal MEM-12 PerCP
-
- Indications d'application
-
Flow cytometry: Recommended dilution: 2 μg/mL, positive control: B-lymphocytes, monocytes, DAUDI cell line, RAJI cell line.
Western blotting and Immunoprecipitation: Positive control: B-lymphocytes, monocytes, DAUDI cell line, RAJI cell line, non-reducing conditions. - Restrictions
- For Research Use only
-
- Concentration
- 1 mg/mL
- Buffer
- Phosphate buffered saline (PBS), pH 7.4, 15 mM sodium azide
- Agent conservateur
- Sodium azide
- Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Conseil sur la manipulation
- Do not freeze.
- Stock
- 4 °C
- Stockage commentaire
- Store at 2-8°C. Do not freeze.
-
-
: "Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens." dans: Tissue antigens, Vol. 28, Issue 5, pp. 288-97, (1987) (PubMed).
-
: "Characterization of seven new monoclonal antibodies against human DR, DR + DP and DQ1 + DQ3 antigens." dans: Tissue antigens, Vol. 28, Issue 5, pp. 288-97, (1987) (PubMed).
-
- Antigène
- HLA-DR
- Autre désignation
- HLA-DR (HLA-DR Produits)
- Sujet
- HLA-DR, a member of MHC class II glycoproteins, that bind intracellularly processed peptides and present them to the Th cells, is composed of 36 kDa alpha chain and 27 kDa beta chain, both anchored in the plasma membrane. Together with other MHC II molecules HLA-DR plays a central role in the immune system.
- Pathways
- Human Leukocyte Antigen (HLA) in Adaptive Immune Response
-
